The effect of synthetic α-tricalcium phosphate on osteogenic differentiation of rat bone mesenchymal stem cells.
Jinzhong Liu,Liang Zhao,Ling Ni,Chunyan Qiao,Daowei Li,Hongchen Sun,Zongtao Zhang
2015-01-01
American journal of translational research
Abstract:The reconstruction of large bone defects has been the focus in bone tissue engineering research. By acting as synthetic frameworks for cell growth and tissue formation, biomaterials can play a critical role in bone tissue engineering. Among various biomaterials, calcium phosphate based materials include hydroxyapatite (HA), alpha-tricalcium phosphate (alpha-TCP), and beta-tricalcium phosphate (beta-TCP) are widely used as scaffold materials in bone tissue engineering. However, little is known about the effect of alpha-TCP alone on the osteogenic differentiation of the BMSCs. To this end, we synthesized alpha-TCP using a novel co-precipitation method. The synthetic alpha-TCP was then incubated with rat BMSCs under osteogenic inductive medium culture conditions, followed by the analysis of the mRNA levels of various osteogenesis-related genes, including ALP, Rux2, COL-I, and SP7, using a quantitative RTPCR method. Following incubation of BMSCs with 20 mu g/ml alpha-TCP, cells reached confluency after 7 days. Additionally, the MTT analysis showed that alpha-TCP at concentration of 10-20 mu g/ml had good biocompatibility with BMSCs, showing no significant inhibition of rat BMSCs proliferation. Furthermore, the synthetic alpha-TCP (20 mu g/ml), when incubated with rat BMSCs in the osteogenic culture medium, increased the mRNA levels of various osteogenesis-related genes, including ALP, Rux2, COL-I, and SP7. Finally, treatment of synthetic alpha-TCP (20 mu g/ml) potentiated calcium nodule formations after incubation with rat BMSCs in osteogenic culture medium for 21 days, as compared with non-treated control. Taken together, the results in the present study suggested that alpha-TCP alone likely promotes rat BMSCs osteogenic differentiation through up-regulating ALP, Col-I, Runx2, and SP7 gene expression.